Pulmonx Q3 2024 GAAP EPS $(0.36) Beats $(0.45) Estimate, Sales $20.387M Beat $20.288M Estimate
pulmonx -4.54%
pulmonx LUNG | 7.36 | -4.54% |
Pulmonx (NASDAQ:
LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.45) by 20 percent. The company reported quarterly sales of $20.387 million which beat the analyst consensus estimate of $20.288 million by 0.49 percent. This is a 15.39 percent increase over sales of $17.668 million the same period last year.